USGO
$3.66-$0.40 (-9.9%)
Last close · Data as of Nov 20, 2026
Price chart
Technical chartScreen technicals →A period is left blank when the price history is shorter than the period.
Daily closes.
Go deeper
Technical chart: candles, 28 indicators including moving averages, RSI and MACD, drawing tools and five colour themes
Performance
Price return, before dividends, to the 20 Nov 2026 close.
- 1M
- -34.0%
- 3M
- -60.2%
- 6M
- -66.9%
- 1Y
- Short history
- 5Y
- Short history
- A period is left blank when the price history is shorter than the period.
52-week range
Day change -$0.40 (-9.9%) from $4.06 to $3.66 · Last close Nov 20, 2026
News & filings
What USGO filed, who traded, and what's next
How to read this
"News & filings" lists what the company itself has put on record with regulators, who inside it traded, the news that names it, and the next date we know of. Filings and releases are first-hand; news is third-party and may be thin for smaller companies. A day of insider filings is one row. Nothing here is a recommendation.
AI Summary
US StockNo rule stands out for this company on the data on file as of 20 Nov 2026.
- Financial statements for this company are not on file.
Prices to the 20 Nov 2026 close
Rule-based from financial data. Not advice.
About the company
U.S. GoldMining Inc., an exploration stage company, engages in the exploration and development of mineral properties in the United States. Its primary asset is the 100%-owned Whistler exploration property, a gold-copper exploration project comprising 377 mining claims covering an area of 217.5 square kilometers located in Yentna Mining District, Alaska. The company was incorporated in 2015 and is based in Anchorage, Alaska. U.S. GoldMining Inc. operates as a subsidiary of GoldMining Inc.
Key statistics
Screen fundamentals →Valuation, profitability, growth and solvency at the latest close; hover a label for its meaning.
Valuation
- 52-week high
- $13.53
- 52-week low
- $3.66
Growth
No growth data available.
No growth data available.
Monthly returns
Month-by-month returns of USGO across the years, with the seasonal pattern.
Market cap against peers
8 peers: same sector, nearest by size.
P/E against peers
Most of this group is loss-making, so EV / Sales is compared for the companies without a P/E.
Not shown (no positive earnings and no EV / Sales): USGO, Tvardi Therapeutics, Inc.
Peer comparison
Same-sector peers by market cap, with the median.
| Company | Market cap | P/E | P/B | ROE | EV/EBITDA |
|---|---|---|---|---|---|
| USGOUSGOthis company | — | — | — | — | — |
| INmune Bio Inc.INMB | $35.9M | -0.8x | 1.5x | -195.3% | -0.4x |
| Neonode Inc.NEON | $31.0M | 3.7x | 1.3x | 34.4% | 0.8x |
| Tvardi Therapeutics, Inc.TVRD | $28.9M | -1.6x | 1.4x | -87.0% | -0.3x |
| GoHealth, Inc.GOCO | $21.4M | -0.1x | 0.6x | -678.9% | -2.0x |
| Sleep Number CorporationSNBR | $8.1M | — | — | 22.8% | 105.2x |
| zSpace, Inc.ZSPC | $959.7k | -0.0x | -0.0x | 112.8% | -0.8x |
| Trinseo PLCTSEOF | $475.3k | -0.0x | -0.0x | 49.7% | 39.4x |
| ACCO Brands CorporationACCO | $0.00 | 0.0x | 0.0x | 6.2% | 5.1x |
| Peer median | — | -0.0x | 0.6x | 14.5% | 0.2x |
Year-to-date ROI
USGO since 1 January, against earlier years.
Historical volatility
USGO's day-to-day swings over 30, 60 and 180 days.
Financial statements
Income statement, balance sheet and cash flow as reported, grouped into plain-language lines.
No financial statement data available.
Learn while you research
Academy chapters picked for USGO and the metrics on this page.
- 01 Stock Valuation BasicsHow to think about what a fair price for a stock looks like.7 min read
- 02 Essential Stock RatiosP/E, P/B, EV/EBITDA, what they mean and when to use each.7 min read
- 03 How to Read a Cash-Flow StatementProfit can be manipulated; cash flow rarely lies.7 min read